Literature DB >> 14526343

Maternal serologic screening for toxoplasmosis.

Jennifer A Pinard1, Nan S Leslie, Pamela J Irvine.   

Abstract

Congenital toxoplasmosis is a rare, but potentially serious, problem during pregnancy. Toxoplasmosis is caused by a protozoal parasite that can be found in warm-blooded animals (including humans); dried cat feces, contaminated soil, or contaminated water; and raw or undercooked meat containing infective tissue cysts. Although cats play a role in the epidemiology of the disease, there is no statistical correlation between toxoplasmosis infection and cat ownership. Toxoplasmosis can be transmitted to the fetus in utero through transplacental transmission. Both the incidence of placental transmission and severity of congenital disease depend on gestational age at which maternal seroconversion occurs. Although transmission rates from mother to fetus tend to be low early in pregnancy, fetal disease severity is highest when the fetus is infected early in gestation. Serological tests to determine maternal seroconversion are available, but their use can pose ethical and practical dilemmas. Universal maternal screening is not currently warranted in the United States because disease prevalence is low.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526343     DOI: 10.1016/s1526-9523(03)00279-4

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  7 in total

1.  Towards Universal Screening for Toxoplasmosis: Rapid, Cost-Effective, and Simultaneous Detection of Anti-Toxoplasma IgG, IgM, and IgA Antibodies by Use of Very Small Serum Volumes.

Authors:  Swinburne A J Augustine
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

2.  Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy.

Authors:  P Valentini; D Buonsenso; G Barone; D Serranti; R Calzedda; M Ceccarelli; D Speziale; R Ricci; L Masini
Journal:  J Perinatol       Date:  2014-09-11       Impact factor: 2.521

3.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

4.  Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India.

Authors:  Munmun Das Sarkar; B Anuradha; Neelam Sharma; Rabindra Nath Roy
Journal:  J Health Popul Nutr       Date:  2012-03       Impact factor: 2.000

5.  Sero-diagnostic evaluation of Toxoplasma gondii recombinant Rhoptry antigen 8 expressed in E. coli.

Authors:  Parthasarathy Sonaimuthu; Mun Yik Fong; Ramaswamy Kalyanasundaram; Rohela Mahmud; Yee Ling Lau
Journal:  Parasit Vectors       Date:  2014-07-01       Impact factor: 3.876

Review 6.  A Comprehensive Review of Common Bacterial, Parasitic and Viral Zoonoses at the Human-Animal Interface in Egypt.

Authors:  Yosra A Helmy; Hosny El-Adawy; Elsayed M Abdelwhab
Journal:  Pathogens       Date:  2017-07-21

7.  Seroprevalence and Risk Factors of Toxoplasma gondii Infection among Cat Sitters in Korea.

Authors:  Bong-Kwang Jung; Hyemi Song; Sang-Eun Lee; Min-Jae Kim; Jaeeun Cho; Eun-Hee Shin; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2017-04-30       Impact factor: 1.341

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.